+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Enhanced cytostatic activity of statins in mouse mammary carcinoma cells overexpressing β2-chimaerin



Enhanced cytostatic activity of statins in mouse mammary carcinoma cells overexpressing β2-chimaerin



Molecular Medicine Reports 2(1): 97-102



The statins, a family of cholesterol-lowering drugs, are known to block the formation of isoprenoids. They thus affect the small GTPase Rho, which requires attachment to cell membranes for proper signaling activity. Chimaerins are GTPase-activating proteins (GAPs) that accelerate GTP hydrolysis from Rac, another GTPase of the same family. We explored the cooperative antitumor effects of the overexpression of β2-chimaerin in combination with statins. F3II mouse mammary carcinoma cells transfected with the β2-chimaerin GAP domain exhibiting low intracellular levels of active Rac-GTP were exposed in vitro to a panel of statins. Transfectants were significantly more sensitive to the cytostatic effects of lovastatin, simvastatin, atorvastatin and rosuvastatin than untransfected F3II cells with high Rac-GTP levels. Transfected tumor cells also showed a higher sensitivity for detachment from the substrate and for apoptosis after statin exposure. We further checked the cytostatic effect of statins in combination with azathioprine, a compound that specifically blocks Rac1 activation. Combined treatment with simvastatin and azathioprine demonstrated an enhanced growth-inhibitory effect on control F3II cells. Our data suggest that the combination of statins with a reduction in active Rac levels can produce a cooperative antitumor effect on breast cancer cells.

(PDF emailed within 0-6 h: $19.90)

Accession: 052982998

Download citation: RISBibTeXText

PMID: 21475797

DOI: 10.3892/mmr_00000068


Related references

Inhibition of aggressiveness of metastatic mouse mammary carcinoma cells by the beta2-chimaerin GAP domain. Cancer Research 63(9): 2284-2291, 2003

Expression of beta2-chimaerin GAP domain reduces aggressiveness of metastatic mouse mammary carcinoma cells. Proceedings of the American Association for Cancer Research Annual Meeting 43: 1064, 2002

Calmodulin-mediated activation of Akt regulates survival of c-Myc-overexpressing mouse mammary carcinoma cells. Journal of Biological Chemistry 279(37): 38903-38911, 2004

Role of beta2-chimaerin in the behaviour of murine mammary carcinoma cells in response to extracellular matrix components. International Journal of Molecular Medicine 15(1): 91-95, 2004

Enhanced metastatic capacity of mouse mammary carcinoma cells transfected with h ras. British Journal of Cancer 51(4): 586, 1985

Enhanced spontaneous metastatic capacity of mouse mammary carcinoma cells transfected with h ras. Hellmann, K And S A Eccles (Ed ) Treatment Of Metastasis: Problems And Prospects; Meeting, London, England, Oct 15-17, 1984 Xiv+406p Taylor And Francis: Philadelphia, Pa , Usa; London, England Illus 385-388, 1985

Highly selective cytostatic activity of e 5 2 bromovinyl 2' deoxyuridine derivatives for murine mammary carcinoma fm 3a cells transformed with the herpes simplex virus type 1 thymidine kinase gene. Molecular Pharmacology 28(6): 581-587, 1985

Novel syngeneic mouse mammary carcinoma cell lines from aggressive ErbB2/Neu-overexpressing/PTEN-deficient tumors. Oncology Reports 33(1): 179-184, 2015

Cytostatic activity of an estradiol-linked nitrosourea in MXT mammary carcinoma and L 5222 leukemia. Arzneimittel-Forschung 39(12): 1577-1579, 1989

Rat mammary adenocarcinoma cells overexpressing the transferrin receptor exhibit an enhanced experimental metastatic growth response. Proceedings of the American Association for Cancer Research Annual Meeting (41): 432, 2000

In-vitro testing of the sensitivity of mammary carcinoma cells to cytostatic drugs. Deutsche Medizinische Wochenschrift 100(40): 2035-2042, 1975

Possibility of in vitro alterations in cultures of mammary carcinoma cells, and altered immunological response in the rat: acquired capacity to reject injections of mammary carcinoma cells and implants of mammary carcinoma. British Journal of Cancer 26(4): 315-320, 1972

Increased activity of mouse mammary adeno carcinoma mitochondria isolated from dissociated cells. Journal of Cell Biology 67(2 PART 2): 278A, 1975

Thymidylate synthase is the principal target enzyme for the cytostatic activity of e 5 2 bromovinyl 2' deoxyuridine against murine mammary carcinoma fm3a cells transformed with the herpes simplex virus type 1 or type 2 thymidine kinase gene. Molecular Pharmacology 32(3): 410-416, 1987

Activity of Listeria monocytogenes attenuated culture on the course of mouse transplantable sarcoma, of mouse mammary carcinoma, and of a canine carcinoma. 1975